Belgium· BE-AMP-SAM371856-00

Tepadina 100 mg

A thiotepa product containing thiotepa, registered in Belgium by Adienne. The same ATC class is registered in 16 of our 19 countries.

ATC L01AC01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTepadina 100 mgATCL01AC01REGISTER NO.BE-AMP-SAM371856-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Thiotepa is registered in 16 of 19 countries.

Countries holding a registration under ATC L01AC01 (thiotepa), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Thiotepa · ATC L01AC01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Thiotepa
Manufacturer
Adienne
Country
Belgium (BE)
ATC code
L01AC01
ATC class
Thiotepa
Defined daily dose
1.62 g, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7719347
  • be_apb
    3595626

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

202 interactions on record for thiotepa.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Thiotepa · interactions on record

202 records

  • 43 severe
  • 105 moderate
  • 14 minor
  • 40 info

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • CyclophosphamideL01AA01severe
  • ChlorambucilL01AA02severe
  • MelphalanL01AA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thiotepa in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thiotepa products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Thiotepa Fresenius Kabi
  • Bulgaria · Тиотепа Msn
  • Czechia · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Germany · Thionovia, Thiotepa Fresenius Kabi
  • Denmark · Thiotepa Abcur, Thiotepa Fresenius Kabi
  • Estonia · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Spain · Thionovia, Thiotepa Vivanta
  • Finland · Thiotepa Abcur, Thiotepa Fresenius Kabi
  • France · Thionovia, Thiotepa Fresenius Kabi
  • United Kingdom (Northern Ireland) · Thiotepa, Thiotepa Hikma Farmacêutica (Portugal)
  • Croatia · Tiotepa Fresenius Kabi, Tiotepa Msn
  • Hungary · Thiotepa, Thiotepa Medac
  • Ireland · Thiotepa Fresenius Kabi
  • Iceland · Tepadina, Thiotepa Abcur
  • Italy · Thionovia, Thiotepa Medac
  • Liechtenstein · Tepadina, Thiotepa Riemser
  • Lithuania · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Latvia · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Netherlands · Thiotepa Fresenius Kabi, Thiotepa Medac
  • Norway · Tepadina, Thiotepa Abcur
  • Poland · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Portugal · Tiotepa Fresenius Kabi, Tiotepa Hikma
  • Romania · Thiotepa Fresenius Kabi, Thiotepa Msn
  • Sweden · Thionovia, Thiotepa Abcur
  • Slovenia · Thiotepa Msn
  • Slovakia · Thiotepa Fresenius Kabi, Thiotepa Msn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c86d5c4a-669c-4695-930a-c68f20c3f3a3
GET /v1/drugs/c86d5c4a-669c-4695-930a-c68f20c3f3a3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tepadina 100 mg",
  "name_fr": "Tepadina 100 mg",
  "name_nl": "Tepadina 100 mg",
  "amp_code": "SAM371856-00",
  "strengths": [
    "100.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Thiotepa"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Thiotepa",
  "authorisation_numbers": [
    "EU/1/10/622/002"
  ]
}

See everything about thiotepa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.